Peter is a chartered accountant by training with over 35 years’ experience in the commercial exploitation of healthcare related technologies in both private and public companies. He has held senior roles with a range of responsibilities including 10 years in venture capital and was the founding Chief Executive of Cambridge Innovation Capital Plc, an investment fund focussing on technology investments arising from the University of Cambridge.
In 1984, he joined his first technology business, Agricultural Genetics Ltd, moving after four years to the diagnostic business Cambridge Life Sciences Plc. Over a two-year period he was instrumental in its reorganisation and trade sale, leaving at that time to join Enzymatix Ltd, out of which was spun a number of technologies and businesses. One of these was Chiroscience Group Plc where he was a co-founder and as Finance Director led the £102m initial public offering in March 1994.
In 1996 he co-founded the venture capital firm Merlin Biosciences as its UK Managing Director and was responsible for many early stage healthcare investments. Six of these were investments backing spin-outs from UK universities which he helped to build; four of these became public companies and the private company BioVex was sold for a consideration of up to $1bn. Another investment was Arakis whom he joined in a full-time capacity in 2004 and then subsequently led the negotiations for its sale to the Japanese biotech company Sosei for £106m.
An experienced public and private company Non-Executive Director, he has served on over 30 boards during his career including SpringWorks Therapeutics Inc, a rare disease company supported by LifeArc that successfully listed on NASDAQ in September 2019. He is currently a Director of Endomagnetics Ltd, a company improving cancer surgery outcomes, and recent Directorships include the Biotechnology Growth Trust Plc, a £300m investment trust investing in global biotechnology, Abcam Plc, the leading supplier of protein research tools, where he was the Senior Independent Director and Chairman of the medical device company, Oval Medical Ltd.Back to our trustees